ROLE OF Nna1 IN RETINAL AND CEREBELLAR NEURODEGENERATION
Nna1 在视网膜和小脑神经变性中的作用
基本信息
- 批准号:7486853
- 负责人:
- 金额:$ 25.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-01 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:Age-MonthsAllelesAmino AcidsAntibodiesApoptosisAutophagocytosisBacterial Artificial ChromosomesBiochemicalBiological AssayBrain StemCandidate Disease GeneCarboxypeptidaseCell FractionationCellsCessation of lifeCharacteristicsChromosomes, Human, Pair 13Cleaved cellDefectDegenerative DisorderDevelopmentDiseaseDrosophila genusElectron MicroscopyFollow-Up StudiesFutureGenesGoalsHomologous GeneHomozygoteHumanImmunohistochemistryLibrariesLifeMale SterilityMapsMeasurableMindMolecularMothsMouse ProteinMusMutationNatureNecrosisNerve DegenerationNeurologicNeurologic Mutants MiceNeuronsPathway interactionsPatternPeptide HydrolasesPhenotypePhotoreceptorsPopulationProcessProteinsPurkinje CellsRecombinantsResearch PersonnelResourcesRetinaRetinalRetinal DiseasesRetinal PhotoreceptorsRoleSequence AnalysisSouthern BlottingSystemTestingThalamic structureTimeTissuesTransgenic OrganismsWestern BlottingYeastsZincbasecell typedayin vivoinsightloss of functionneuron lossolfactory bulbprogramstransgene expressionyeast two hybrid system
项目摘要
DESCRIPTION (provided by applicant): Despite significant advances in our understanding of degenerative diseases of the brainstem and retina, the pathways that underlie most of these disease processes remain undefined. Furthermore, the basis for cell-type specific degeneration and neuron cell death in many important neurological and retinal diseases is unknown. With these issues in mind, we hypothesized that delineation of the molecular basis of the neurological mouse mutant, Purkinje cell degeneration (pcd), would yield insights into how and why certain types of neurons degenerate. pcd is an autosomal recessive mutation that produces a non-developmental degeneration of cerebellar Purkinje cells and retinal photoreceptors. To determine the basis of the degeneration in pcd, we mapped the pcd gene defect to a 1 cM region on chromosome 13 and then identified mutations in the Nna1 gene in two alleles of pcd. Nna1 is a predicted 1218 amino acid protein that has a zinc carboxypeptidase domain with highly conserved orthologues in human (NNA1) and Drosophila (NnaD). Additional homologues of Nna1 exist in mouse, human, moth, and worms, all of which retain the carboxypeptidase domain. Using the results and resources that we have generated, we now wish to advance our understanding of how loss of Nna1 function leads to cell-type specific neurodegeneration in pcd, and thereby determine if Nna1's pathway of action has implications for other diseases. To accomplish these goals, we will begin by confirming that Nna1 is the causal gene by attempting transgenic rescue of the entire pcd phenotype and of one selected neuronal population, namely Purkinje cells. We will seek the mutations responsible for remaining pcd alleles. We will study the expression characteristics of the Nna1 gene product, and will define the nature of neuronal death in pcd mice. We will evaluate Nna1 for carboxypeptidase activity and will determine if retention of carboxy-peptidase activity is required for successful transgenic rescue. To identify Nna1's pathway of action, we will use lines of Drosophila that carry NnaD loss-of-function alleles to perform modifier screens to identify NnaD interacting genes. We will characterize Nna1 interacting proteins detected in a yeast two-hybrid screen, and will compare the results of these two screens to guide future studies.
描述(由申请人提供):尽管我们对脑干和视网膜退行性疾病的理解取得了重大进展,但大多数这些疾病过程背后的途径仍然不明确。此外,许多重要的神经系统和视网膜疾病中细胞类型特异性变性和神经元细胞死亡的基础尚不清楚。考虑到这些问题,我们假设,对神经小鼠突变体浦肯野细胞变性(pcd)的分子基础的描述,将有助于深入了解某些类型的神经元如何以及为何退化。 pcd 是一种常染色体隐性突变,会导致小脑浦肯野细胞和视网膜感光细胞发生非发育性变性。为了确定 PCD 变性的基础,我们将 PCD 基因缺陷定位到 13 号染色体上的 1 cM 区域,然后鉴定了 PCD 两个等位基因中 Nna1 基因的突变。 Nna1 是一种预测的 1218 个氨基酸蛋白,具有锌羧肽酶结构域,在人类 (NNA1) 和果蝇 (NnaD) 中具有高度保守的直系同源物。 Nna1 的其他同源物存在于小鼠、人类、飞蛾和蠕虫中,所有这些都保留了羧肽酶结构域。利用我们产生的结果和资源,我们现在希望加深对 Nna1 功能丧失如何导致 PCD 中细胞类型特异性神经变性的理解,从而确定 Nna1 的作用途径是否对其他疾病有影响。为了实现这些目标,我们将首先通过尝试对整个 PCD 表型和一个选定的神经元群体(即浦肯野细胞)进行转基因拯救来确认 Nna1 是致病基因。我们将寻找导致剩余 PCD 等位基因的突变。我们将研究 Nna1 基因产物的表达特征,并定义 PCD 小鼠神经元死亡的性质。我们将评估 Nna1 的羧肽酶活性,并将确定成功的转基因拯救是否需要保留羧肽酶活性。为了确定 Nna1 的作用途径,我们将使用携带 NnaD 功能丧失等位基因的果蝇品系进行修饰筛选,以识别 NnaD 相互作用基因。我们将表征在酵母双杂交筛选中检测到的 Nna1 相互作用蛋白,并将比较这两个筛选的结果以指导未来的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALBERT R LA SPADA其他文献
ALBERT R LA SPADA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALBERT R LA SPADA', 18)}}的其他基金
Molecular genetic regulation of autophagy in health and neurodegenerative disease
健康和神经退行性疾病中自噬的分子遗传调控
- 批准号:
10367877 - 财政年份:2022
- 资助金额:
$ 25.38万 - 项目类别:
Ataxia Investigators Meeting 8: Leveraging Therapeutic Opportunity into Novel Treatment Paradigms
共济失调研究者会议 8:利用治疗机会开发新型治疗范式
- 批准号:
9913421 - 财政年份:2020
- 资助金额:
$ 25.38万 - 项目类别:
Deconstructing the cellular and molecular basis of SBMA motor neuron disease: From mechanism to therapy
解构 SBMA 运动神经元疾病的细胞和分子基础:从机制到治疗
- 批准号:
10355757 - 财政年份:2016
- 资助金额:
$ 25.38万 - 项目类别:
Deconstructing the cellular and molecular basis of SBMA motor neuron disease: From mechanism to therapy
解构 SBMA 运动神经元疾病的细胞和分子基础:从机制到治疗
- 批准号:
9535519 - 财政年份:2016
- 资助金额:
$ 25.38万 - 项目类别:
Ataxin-7 oligonucleotide knock-down to treat SCA7 retinal and cerebellar disease
Ataxin-7 寡核苷酸敲低治疗 SCA7 视网膜和小脑疾病
- 批准号:
8774128 - 财政年份:2014
- 资助金额:
$ 25.38万 - 项目类别:
Ataxin-7 oligonucleotide knock-down to treat SCA7 retinal and cerebellar disease
Ataxin-7 寡核苷酸敲低治疗 SCA7 视网膜和小脑疾病
- 批准号:
9321472 - 财政年份:2014
- 资助金额:
$ 25.38万 - 项目类别:
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
玉米穗行数QTL克隆及优异等位基因型鉴定
- 批准号:
- 批准年份:2022
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Folate and PSMA Interact to Regulate DNA Methylation and Prostate Carcinogenesis
叶酸和 PSMA 相互作用调节 DNA 甲基化和前列腺癌发生
- 批准号:
8610804 - 财政年份:2010
- 资助金额:
$ 25.38万 - 项目类别: